Ignite Creation Date:
2024-05-05 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00527566
Status:
COMPLETED
Last Update Posted:
2017-03-22
First Post:
2007-09-07
Brief Title:
Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Organization Data
Organization:
Brigham and Womens Hospital
Class:
OTHER
Study ID:
2007-P-0000121BWH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Brigham and Womens Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Wechsler MD
Responsible Party Title:
Assistant Professor of Medicine at Harvard Medical School and Brigham and Womens Hospital
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Brigham and Womens Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |